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Entry
Interferon, type IChronic immune activation, triggered by plasmacytoid dendritic cell (PDC) interferon (IFN)-alpha produc-
tion, plays an important role in HIV-1 pathogenesis. As the entry of HIV-1 seems to be important for the ac-
tivation of PDC, we directly characterized the viral entry into these cells using immuno-electron microscopy,
cellular fractionation, confocal imaging, and functional experiments. After attachment to PDC, viruses were
taken up in an energy-dependent manner. The virions were located in compartments positive for caveolin;
early endosomal antigen 1; Rab GTPases 5, 7 and 9; lysosomal-associated membrane protein 1. PDC harbored
more virus in endocytic vesicles than CD4+ T cells (pb0.05). Blocking CD4 inhibited the uptake of virions
into cytosolic and endosomal compartments. Dynasore, an inhibitor of dynamin-dependent endocytosis,
not the fusion inhibitor T-20, reduced the HIV-1 induced IFN-alpha production. Altogether, our morphologi-
cal and functional data support the role of endocytosis for the entry and IFN-alpha induction of HIV-1 in PDC.
© 2011 Elsevier Inc. All rights reserved.Introduction
Chronic immune stimulation with high T cell turnover rates and ap-
optosis has been identiﬁed as a major hallmark of pathogenic lentiviral
infection (Kirchhoff, 2009). In HIV-1 infected patients, the degree of im-
mune stimulation is more closely associated with progression to AIDS
than viral load (Giorgi et al., 1999; Sousa et al., 2002). An important
stimulus triggering immune activation is the type I interferon (IFN) pro-
duction, which drives a potent Th1 polarization (Cella et al., 2000). The
IFN-alpha induction by (non)-infectious HIV-1 particles enhances the
expression of the TNF-related apoptosis-inducing ligand (TRAIL) and
its death receptor (DR) 5 on CD4+ T lymphocytes in the peripheral
blood and in secondary lymphatic tissue (Herbeuval et al., 2005b,
2006), resulting in the apoptosis of uninfected CD4+ bystander T cells
which correlates with progression to disease (Herbeuval et al., 2005a).
In primate lentiviral models, pathogenic SIV infections have also been
associated with increased IFN-alpha and TRAIL levels (Mandl et al.,
2008; Meythaler et al., 2009).
In 1999, plasmacytoid dendritic cells (PDC) were identiﬁed as
major producers of type I IFN in the blood (Cella et al., 1999; Siegal
et al., 1999). These cells, although accounting for only 0.2–0.5% of periph-
eral bloodmononuclear cells (PBMC), play an important role in innate im-
mune defenses against bacterial and viral pathogens (Fitzgerald-Bocarsly(B. Schmidt).
rights reserved.and Feng, 2007). PDC express the endosomal Toll-like receptors (TLR)
7 and 9, which, after detection of single-stranded RNA and CpG-like
DNA molecules, respectively, initiate a downstream signaling cas-
cade resulting in the transcription of proinﬂammatory cytokines
and interferons (Gilliet et al., 2008). These soluble factors orches-
trate the early immune response via stimulation of naïve T cells,
thus linking innate and adaptive immunity (Kadowaki et al., 2000).
High-titered HIV-1 and HIV-infected cells induce major IFN-alpha
production by PDC (Beignon et al., 2005; Fong et al., 2002; Fonteneau
et al., 2004; Herbeuval et al., 2005a, 2005b; Schmidt et al., 2005;
Yonezawa et al., 2003). The underlying mechanism for the PDC activa-
tion involves the interaction of the HIV-1 envelope protein gp120
with the CD4 receptor on PDC, supported by the ﬁnding that the afﬁnity
of gp120 to CD4 determines the degree of IFN-alpha production (Haupt
et al., 2008). The HIV-1 coreceptors CXCR4 and CCR5 appear to play a
role in the productive infection of PDC (Schmidt et al., 2004), but are
dispensable for IFN-alpha induction (Beignon et al., 2005; Haupt et al.,
2008; Herbeuval et al., 2005b; Schmidt et al., 2005). The IFN-alpha pro-
duction is not affected by fusion inhibitors, but can be blocked by lyso-
somotropic drugs such as chloroquin, baﬁlomycin, and ammonium
chloride, which provide indirect evidence for the uptake of HIV-1 by en-
docytosis (Beignon et al., 2005; Hardy et al., 2007; Schmidt et al., 2005).
Recombinant virions deﬁcient in viral RNA packaging were profoundly
impaired in IFN-alpha induction, suggesting viral nucleic acids interact
with TLR 7 as stimulatory component (Beignon et al., 2005). A recent
study conﬁrmed the role of TLR 7 and suggested cytoplasmic receptors
as additional sensors for HIV-infected cells (Lepelley et al., 2011).
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mediated endocytosis, macropinocytosis and phagocytosis. Further
mechanisms have emerged, but are less well characterized. Clathrin-
and caveolin-mediated endocytosis can be identiﬁed by their respective
vesicle coat protein. Both entry mechanisms are dependent on the cyto-
solic GTPase dynamin that promotes pinching off the primary endocytic
vesicles from the plasma membrane. Once internalized, viruses are rou-
ted to early endosomes, which contain the Rab GTPase 5 and the early
endosomal antigen 1 (EEA-1) (Mu et al., 1995; Rubino et al., 2000). The
trafﬁcking pathway continues towards late endosomes, characterized
by the Rab proteins 7 and 9, and lysosomes in which the lysosomal-
associated membrane protein 1 (LAMP-1) is highly enriched. Moreover
viral particles can be recycled to the cell surface in CD71-positive vesicles
(Di Pucchio et al., 2008). Tetraspanins like CD63 andCD81have also been
reported to play a role in the pathogenesis of HIV-1 in CD4+ T cells and
antigen-presenting cells. In this respect, tetraspanin microdomains may
facilitate HIV-1 binding by clustering the receptor CD4 or the coreceptors
(Martin et al., 2005; Mercer et al., 2010; Schelhaas, 2010; van Spriel and
Figdor, 2010).
The entry of HIV-1 into PDC has so far only been assessed by indirect
methods, namely the effect of inhibitors of the endosomal acidiﬁcation
on the HIV-1 induced IFN-alpha production. In our current study, we
aimed to directly visualize and further characterize the uptake mecha-
nism using immuno-electron microscopy, cellular fractionation, and
confocal imaging. These approaches togetherwith the analysis of differ-
ent entry inhibitors on the IFN-alpha production provided morphologi-
cal and functional evidence for a CD4- and dynamin-dependent uptake
of HIV-1 into PDC. This entry mechanism, which appears to be a major
factor in the HIV-1 immunopathogenesis, may represent a new thera-
peutic target for AIDS and its related disorders.
Results
Attachment and uptake of viral particles into PDC
IFN-alpha induction byHIV-1 andHIV-infected cells can be inhibited
by blocking endosomal acidiﬁcation (Beignon et al., 2005; Hardy et al.,
2007; Martinson et al., 2010; Schmidt et al., 2005), providing indirect
evidence for the endocytosis of viral particles. To directly visualize this
process, we analyzed the entry of the X4-tropic primary isolate HIV-
1SF33 and the molecular clone HIV-1NL4-3 into PDC using transmission
electron microscopy in combination with pre- and post-embedding
immunostaining. The images presented are taken from a series of 11
independent experiments. HIV-1 attached to the dendrites of PDC
(Fig. 1A), conﬁrmed by staining with anti-p24 and a Gold-conjugated
IgG (Fig. 1B). Gold-covered particles were also detected in intracellular
vesicles of PDC (Fig. 1C).When HIV-exposed PDCwere stainedwith the
secondary reagent only, Gold particles were absent from the prepara-
tion. Instead, the characteristic morphology of HIV-1 particles was
revealed in more detail (Fig. 1D), most notably the conical capsids
(Fig. 1E). Serial thin section series of virus-containing vesicles, which
were obtained from single cells, suggested that most of the vesicles
were indeed intracellular and not just invaginations of the plasma
membrane (data not shown). When the energy-dependent entry of
HIV-1 was blocked at 4 °C, viral particles still attached to the PDC, how-
ever, uptake was only observed at 37 °C (data not shown). These data
suggest that viral particles, after attachment to PDC, are taken up into
vesicular compartments of these cells.
Presence of HIV-1 in intracellular compartments of PDC
After entry of HIV-1 into PDC, viral capsids were detected in close
proximity to (Fig. 2A) or within vesicular structures of these cells
(Fig. 2B). Some particles appeared to be attached to the vesicular mem-
brane (Fig. 2C), whereas others were free-ﬂoating in this compartment(Fig. 2D). Immunolabeled HIV-1 particles were surrounded by electron-
lucentmaterial, which did onlymarginally stain with anti-p24 (Fig. 2D).
The speciﬁcity of staining was conﬁrmed in neutralization experiments,
in which the p24 antibody was preincubated with a tenfold excess of
p24 antigen (Aalto Bio Reagents Ltd., Dublin, Ireland). This procedure
largely reduced the detection signals in 293T cells transfected with
pNL4-3 in immunoﬂuorescence (Fig. S1A), and in immuno-electron mi-
croscopy (Fig. 1C, Fig. S1B). Unspeciﬁc staining of the p24 antibody was
not observed, using PDC not exposed to HIV-1SF33 (data not shown). Al-
together, the images support the presence of virions in intracellular ves-
icles of PDC.
Enhanced uptake of HIV-1 particles into endosomes of PDC
In a next step, we performed cellular fractionation experiments to
study the distribution of HIV-1 RNA in cytosolic and vesicular com-
partments of CD4+ T cells and PDC. To conﬁrm that vesicles were ef-
fectively separated from the cytosol, Western blot analyses were
performed using an antibody to LAMP-1, which is tightly associated
with vesicular membranes. LAMP-1 was mostly detected in the vesic-
ular fraction, whereas only a faint band was observed in the cytosolic
extract, similarly observed for CD4+ T cells and PDC (Fig. 3A). First,
we analyzed the kinetics of the HIV-1 uptake into CD4+ T cells and
PDC. The HIV-1 RNA increased in both cell populations from 15 to
120 min of incubation, with a more rapid and efﬁcient uptake into
PDC (Fig. 3B). After 45 min, PDC harbored four times more viral
RNA in endosomal vesicles than CD4+ T cells (36,141±10,343 copies/
ml versus 7,953±1,308 copies/ml; p=0.003), determined in 6 and 12
separate experiments, respectively. This difference was still signiﬁcant
for the percentage of HIV-1 RNA in the endosomal fraction of PDC com-
pared to CD4+ T cells (74.1% versus 52.8%, respectively, p=0.03)
(Fig. 3C). Thus, PDC appear to have an increased capacity to endocytose
HIV-1 in comparison to CD4+ T cells.
Role of endocytosis and fusion for the uptake of HIV-1
The extent of fusion and endocytosis for the uptake of HIV-1 into
PDC and CD4+ T cells was analyzed at different inhibitory conditions.
The energy-dependent processes of fusion and endocytosis can be
blocked at 4 °C. Consequently, incubation on ice reduced the HIV-1
RNA in cytosolic and vesicular compartments of PDC and CD4+ T
cells by at least 70% (Fig. 3D). A neutralizing antibody to CD4
(Leu3a) decreased the viral uptake by more than 75% in CD4+ T
cells and to a minor extent in PDC; viral RNA was reduced in vesicular
and cytosolic compartments of CD4+ T cells and in the vesicular frac-
tion of PDC (Fig. 3E). Additionally we evaluated the effect of T-20, a
small C-peptide that prevents fusion of HIV-1 with the cellular mem-
brane by binding to the transmembrane glycoprotein gp41 and inhi-
biting the 6-helix bundle formation (Kilby et al., 1998). T-20
blocked the HIV-1 infection of an indicator cell line (pb0.05) (data
not shown). The abundance of HIV-1 RNA in cellular fractionation ex-
periments, however, was only marginally reduced in CD4+ T cells
and PDC at concentrations of 100 nM and higher (Fig. 3F and data
not shown). In CD4+ T cells, HIV-1 RNA decreased in the cytosol
and increased in the vesicles, whereas in PDC, HIV-1 RNA rather de-
clined in the vesicular fraction. Altogether, inhibitory conditions
revealed comparable HIV-1 RNA changes in PDC and CD4+ T cells,
supporting a similar route of entry in both cell populations.
Dynasore reduces the HIV-1 mediated IFN-alpha induction
To determine further the role of fusion and endocytosis for the up-
take of HIV-1 into PDC, we investigated the effects of T-20 and dyna-
sore on the IFN-alpha production. Dynasore is a small molecule that
inhibits the cytosolic GTPase dynamin and thereby blocks clathrin-
and caveolin-mediated endocytosis (Macia et al., 2006). PDC were
Fig. 1. Attachment and entry of HIV-1 into plasmacytoid dendritic cells (PDC). (A) Transmission electron microscopy and (B–E) immunostaining of PDC exposed to the X4-tropic
primary isolate HIV-1SF33 or the molecular clone HIV-1NL4-3. Figures were either taken from (B) pre-embedding or (C–E) post-embedding immunostaining, using (B, C) a monoclo-
nal antibody to p24 antigen (anti-p24) and a Gold-conjugated anti-human immunoglobulin or (D, E) the secondary reagent only. Arrows point to (D) the uptake of viral particles
into vesicular structures of PDC, and, in more detail, (E) the characteristic morphology of HIV-1 particles. Images are taken from a series of 11 independent experiments using PDC of
different donors.
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HIV-1NL4-3 for 36 h. T-20 neither affected the HIV-1 nor the HSV-1 in-
duced IFN-alpha production (Fig. 4A), suggesting that fusion is not rele-
vant for IFN-alpha induction. On the contrary, dynasore signiﬁcantly
reduced the IFN-alpha induction byHIV-1 to 22.6% in ten separate exper-
iments (pb0.001) (Fig. 4B). In comparison, the IFN-alpha production in
response to the TLR 7 agonist S-27609 was only reduced to 47.13%
(pb0.001). According to previous studies (Carter et al., 2011), we inves-
tigated the effect of dynasore on the PDC activation in the absence of FCS.
The effect of the inhibitor was more pronounced using these conditions.
A toxic effect of dynasore or DMSO on the PDCwas excluded by Annexin
and propidium iodide staining after 36 h of incubation (Fig. 4C). More-
over, we investigated the effect of dynasore on the expression of CD4
and the coreceptors CXCR4 and CCR5 on the PDC. CD4 and CCR5 were
not and CXCR4 slightly but not signiﬁcantly downregulated within 2 h
of incubation, which is considered to be the relevant time frame for the
entry ofHIV-1 (Fig. 4D). In addition,wedirectly studied the effect of dyna-
sore on the uptake of HIV-1 into endosomal compartments of PDC usingconfocal imaging. Dynasore considerably reduced the colocalization of
the viral capsid protein p24 with the early endosomal antigen 1 (EEA-1)
at 15 min of incubation, and with the lysosomal-associated membrane
protein 1 (LAMP-1) at 120 min of incubation (Fig. 4E). Thus, our ﬁndings
suggest that a dynamin-dependent entry mechanism is involved in the
internalization of HIV-1 and subsequent IFN-alpha induction in PDC rath-
er than direct fusion of the virus with the plasma membrane.HIV-1 is targeted to endosomal organelles
To characterize the uptake of HIV-1 into PDC in more detail, we
performed confocal imaging using established markers of endocytic
compartments, including EEA-1 as early and LAMP-1 as late endoso-
mal marker. PDC were exposed to HIV-1SF33 or HIV-1NL4-3 for differ-
ent time periods and then stained with antibodies against the viral
capsid antigen p24 and EEA-1 or LAMP-1. When PDC were kept on
ice during the entire incubation period, only very few red-stained
Fig. 2. Intracellular localization of HIV-1 in plasmacytoid dendritic cells (PDC). Immuno-electron microscopy of PDC exposed to the X4-tropic primary isolate HIV-1SF33 or the mo-
lecular clone HIV-1NL4-3, using a monoclonal antibody to the capsid antigen p24 (anti-p24) and a Gold-conjugated anti-human immunoglobulin. The images were taken from (A-C)
pre-embedding and (D) post-embedding immunostaining. Arrows point to single viral particles, which reside close to or within vesicular structures of PDC.
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face were removed by the extensive washing procedure (Fig. 5A). Sub-
sequent incubation of PDC at 37 °C showed colocalization of HIV-1 with
EEA-1 within 15 min, indicative of rapid uptake into early endosomes
(Fig. 5A). Notably, the extent of colocalization with EEA-1 at 15 min of
incubation (57.41±22.04%) was very similar to data recently published
by others (O'Brien et al., 2011). The colocalization of EEA-1with p24 an-
tigen gradually decreased from 15 min to 120min of incubation, which
proved to be signiﬁcant in statistical trend analysis (p=0.02). In con-
trast, colocalization of p24 antigen with LAMP-1 signiﬁcantly increased
during this time period (pb0.001) (Fig. 5B). This dynamics indicates
that internalized virions are rapidly targeted to early endosomal com-
partments and subsequently transferred to late endosomes/lysosomes,
providing evidence for endocytosis as a relevant entry route of HIV-1
into PDC. The three-dimensional aspect of the colocalization is illustrat-
ed by representative movies, which were obtained from EEA-1 and
LAMP-1 Z-stacks using the Leica Visualization 3D-Projection program
(Suppl. Figs. 2 and 3).
Intracellular trafﬁcking of HIV-1 captured by PDC
To further characterize the compartments in which HIV-1 accu-
mulates in PDC after internalization, we stained for early, maturating,and late endosomes (Rab GTPases 5, 7 and 9) (Mercer et al., 2010;
Schelhaas, 2010), tetraspanins (CD81 and CD63) (van Spriel and
Figdor, 2010), and recycling endosomes (CD71) (Di Pucchio et al.,
2008). The amount of colocalization between HIV-1 and these cellular
markers was quantiﬁed over time. On average, HIV-1 colocalized with
the Rab GTPases in one third of the cells (Fig. 6A). Colocalization with
Rab5 increased from 19% (30 min) to 31% (90 min) of incubation and
decreased thereafter, whereas Rab7 and Rab9 signals slightly in-
creased and did not decline within 120 min of incubation (Fig. S4A).
The tetraspanins showed a strong colocalization for CD81 (37%) and
to a lesser extent for CD63 (23%), whereas less than 7% of the viral cap-
sids overlappedwith the transferrin receptor CD71 (Fig. 6B). Colocaliza-
tion with CD81 and CD63 occurred within 5–60 min of incubation (Fig.
S4B). In conclusion, HIV-1 is rapidly taken up into endosomal compart-
ments positive for CD81, CD63, and Rab GTPases. In contrast, viral cap-
sids appear not to accumulate in CD71-positive vesicles indicating that
HIV-1 is not shuttled back to the cell surface.
Internalization of HIV-1 particles through a Caveolin-1 mediated endocytic
pathway
To verify that viral particles are internalized by a dynamin-dependent
pathway, PDC were exposed to HIV-1NL4-3 as described above, this time
Fig. 3. Distribution of HIV-1 RNA in cytosolic and vesicular compartments of CD4+ T cells and plasmacytoid dendritic cells (PDC). (A) Western Blot analysis of cytosolic and vesic-
ular fractions of CD4+ T cells and PDC exposed to HIV-1SF33, using a monoclonal antibody against the lysosomal-associated membrane antigen 1 (LAMP-1). (B) Time course analysis
of the uptake and cellular distribution of HIV-1 RNA in CD4+ T cells and PDC. The abundance of HIV-1 RNA is shown as mean and standard error of 6–12 separate experiments for
CD4+ T cells, and 3, 6 and 4 separate experiments for PDC exposed to HIV-1 for 15, 45 and 120 min, respectively. (C) Distribution of HIV-1 RNA in cytosolic and vesicular compart-
ments of CD4+ T cells and PDC, representative of 12 and 6 separate analyses, respectively. For each experiment, the HIV-1 RNA in both fractions was set to 100% (HIV-1 RNA ratio),
calculating the proportion of HIV-1 RNA in each fraction. (D–F) Changes in HIV-1 RNA in different cell fractions after exposure of CD4+ T cells and PDC to HIV-1SF33 using (D) in-
cubation at 4 °C, (E) a monoclonal antibody to CD4 (15 μg/ml), or (E) the fusion inhibitor T-20 (100 nM). The HIV-1 RNA in the uninhibited control sample was set to 100%. The
results of CD4+ T cells are presented as mean and standard error of 3–4 separate experiments, the PDC data as mean of two separate experiments for each condition. Statistics
were performed using the Student's t-test for independent and correlated samples, respectively. *pb0.05.
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ticles colocalized with the marker protein for clathrin-mediated endo-
cytosis, whereas 37% overlapped with caveolin-1, a marker protein for
the uptake by caveolae (p=0.02) (Fig. 7A). Colocalization of p24 anti-
gen with caveolin-1 was observed within 5 min of incubation, whereas
costaining with clathrin did not increase within 90 min of incubation.
As a control, we investigated the colocalization of the transferrin recep-
tor CD71 with clathrin, because transferrin is known to be taken up by
clathrin-mediated endocytosis (Ehrlich et al., 2004; Hanover et al.,
1984). CD71 rapidly and efﬁciently colocalized with clathrin within
5 min of incubation (Fig. 7A). These results, along with the reduction
of IFN-alpha production by dynasore known to inhibit clathrin- and
caveolin-mediated endocytosis, indicate that HIV-1 enters PDC at least
in part through a caveolin- and dynamin-dependent pathway prior to
inducing IFN-alpha.
Role of the CD4 receptor in the entry of HIV-1 into PDC
CD4 is well-known as receptor for the envelope-mediated fusion
of HIV-1 with the cellular membrane. To investigate whether this re-
ceptor is also required for the endocytosis of HIV-1 into PDC, blocking
experiments were performed. PDC were preincubated with a neutral-
izing antibody to CD4 (Leu3a) or human IgG as an isotype control at
37 °C for 2 h, and then exposed to HIV-1NL4-3 for 45 min at 37 °C.
Thereafter, cells were labeled with antibodies against the viral capsid
protein p24 and EEA-1. Confocal microscopy revealed that anti-CD4
inhibited the uptake of viral particles into cytosolic and endosomal
compartments of PDC (Fig. 7B). In contrast, viral particles were read-
ily taken up in both compartments in the presence of the isotypecontrol and in mock-treated PDC. Additionally, we studied the effect
of an antibody to BDCA2, a calcium-dependent lectin on the PDC sur-
face, which mediates antigen capture and uptake (Dzionek et al.,
2001) and binds to gp120 (Martinelli et al., 2007). Neither this anti-
body nor its isotype control blocked the internalization of HIV-1
into PDC (Fig. 7B). These results emphasize the crucial role of CD4
for the uptake and internalization of HIV-1 into cytosolic and endoso-
mal compartments of PDC.
Discussion
The entry of HIV-1 into PDC has been addressed by several groups,
providing indirect evidence that endocytosis of virions is required for
the IFN-alpha induction (Fitzgerald-Bocarsly and Jacobs, 2010). Our
study attempted to directly visualize the entry of the X4-tropic primary
isolate HIV-1SF33 or the molecular clone HIV-1NL4-3 into freshly isolated
PDC of healthy donors and elucidate some of the cellular factors required
for successful entry and IFN-alpha induction by HIV-1 in PDC. In a ﬁrst
step, we focused on two-dimensional immuno-electron microscopy,
which permitted us, for the ﬁrst time, to directly visualize the presence
of virions in intracellular vesicles of PDC (Figs. 1, 2). We observed Gold-
covered viral capsids in vesicular structures of PDC in several pre- and
post-embedding approaches in conjunction with control experiments.
However, it has to be considered that this method has its limitations, as
the cellular architecture is not completely illustrated (Bennett et al.,
2009). Although three-dimensional reconstruction indicated that most
of the vesicles were indeed intracellular, we cannot entirely exclude
deep invaginations of the plasma membrane. Notably, the data
obtained by electron microscopy were supported by confocal imaging,
Fig. 4. Effect of T-20 and dynasore on the HIV-1 induced interferon (IFN)-alpha release by plasmacytoid dendritic cells (PDC). PDC were exposed to (A) the fusion inhibitor T-20
(100–300 nM) or (B) dynasore (Dyn.) (80 μM), an inhibitor of the GTPase dynamin, for 30 min and then stimulated with HIV-1NL4-3. UV-irradiated herpes simplex virus type 1
(HSV-1) and the synthetic TLR 7 agonist S-27609 (5 μM) were used as control stimuli. Supernatants were harvested after 36 h and the IFN-alpha levels were determined by
ELISA. Results are given as mean and standard error, representing ten separate experiments using PDC from different donors. In three experiments, PDC were incubated with dyna-
sore and HIV-1 in the absence of fetal calf serum (w/o FCS) for 2 h. ***pb0.001. (C) Annexin and propidium iodide (PI) staining of PDC exposed to mock (grey ﬁlled curve), DMSO
(dotted line) and dynasore (black line) for 36 h. (D) Expression of CD4 and the coreceptors CXCR4 and CCR5 on the PDC after 2 h and 36 h of incubation with DMSO or dynasore.
Data are representative of three and two different donors, respectively. (E) Effect of dynasore on the colocalization of the viral p24 antigenwith the early endosomal antigen 1 (EEA-1) or
the lysosomal-associated membrane protein 1 (LAMP-1). Data are representative of 296 and 236 double-positive cells, respectively, using PDC of two different donors.
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including EEA-1, Rab GTPases, LAMP-1, and tetraspanins CD63 and CD81
(Fig. 5, Suppl. Figs. 2 and 3, Fig. 6). Altogether, our data support the pres-
ence of HIV-1 in endosomes, further corroborated by the results obtained
by cellular fractionation (Fig. 3). Colocalization of HIV-1 with EEA-1 wassimilarly reported by others (O'Brien et al., 2011). In contrast to our data,
they also reported costainingwith CD71, but notwith LAMP-1. These dis-
crepancies may be due to methodological differences like different cell-
culture conditions. While we used a primary HIV-1 isolate and a full-
length proviral clone and stained with an antibody to p24 antigen,
Fig. 5. Uptake of HIV-1 particles into early endosomes and lysosomes of plasmacytoid dendritic cells (PDC). PDC were exposed to the X4-tropic primary isolate HIV-1SF33 or HIV-
1NL4-3 at 4 °C for 30–60 min and then incubated at 37 °C for different time periods. Cells were stained using a biotinylated antibody to the viral p24 capsid antigen (red) and a mono-
clonal antibody (green) against (A) the early endosomal antigen 1 (EEA-1) or (B) the lysosomal-associated membrane protein 1 (LAMP-1). Cell nuclei were stained with DAPI
(blue). For quantiﬁcation, double-positive cells were counted and the proportion of cells with a colocalization event was calculated. Data represent seven independent confocal
experiments for EEA-1, evaluating a total of 162, 182, 109, and 113 double-positive cells for 15–20–60–120 min, and ﬁve separate experiments for LAMP-1, evaluating 255, 182,
278, and 227 double-positive cells for 15–30–60–120 min. Data are given as mean and standard error. Statistical analysis was performed using one way analysis of variance for
trend analysis.
158 K. Pritschet et al. / Virology 423 (2012) 152–164O'Brien and colleagues used GFP-HIV generated using a Vpr mutant and
eGFP-Vpr plasmids (O'Brien et al., 2011).
Entry of HIV-1 can occur as CD4- and coreceptor-dependent fusion
with the cellular membrane and as CD4-mediated, but coreceptor-
independent endocytosis. The latter has been reported for primary
CD4+ T cells (Blanco et al., 2004), and dynamin- and clathrin-
mediated endocytosis for CD4+ HeLa cells (Daecke et al., 2005).
Macropinocytosis was described as entry mechanism for HIV-1 into
macrophages (Marechal et al., 2001), and further pathways have
been addressed (Permanyer et al., 2010). To address the role of fu-
sion and endocytosis for the uptake of HIV-1 into PDC and CD4+ T
cells, we performed cellular fractionation experiments. Although
we have to consider the relatively high background of the HIV-1
RNA, our data suggest a similar route of HIV-1 entry into PDC and
CD4+ T cells. However, PDC harbored more HIV-1 RNA in endo-
somes than CD4+ T cells and thus have an increased capacity of en-
docytosis (Figs. 3B, C). Notably, the colocalization with differentendosomal markers supports the conclusion that a substantial pro-
portion of the HIV-1 particles are taken up into PDC via endocytosis
(Figs. 6, 7A). Moreover, the fusion inhibitor T-20 did not substantial-
ly reduce the abundance of HIV-1 RNA in CD4+ T cells and PDC
(Fig. 3F), which is consistent with a recent report that viral particles
do not fuse at the plasma but the endosomal membrane (Miyauchi
et al., 2009). It has to be considered that these results reﬂect our ex-
perimental conditions, in particular the high viral input, which was
required to visualize the particles. Therefore, the uptake of HIV-1
into PDC may differ under more physiological conditions. The entry
via endocytosis, however, may be favorable for HIV-1 because anti-
bodies or entry inhibitors like T-20 do not readily gain access to
this compartment.
In addition, we adopted a functional approach evaluating the ef-
fect of T-20 or dynasore on the HIV-1 induced IFN-alpha production.
IFN-alpha induction was not affected by the fusion inhibitor T-20,
but was sensitive to dynasore (Fig. 4), which prevents the dynamin-
Fig. 6. Intracellular trafﬁcking of HIV-1 captured by plasmacytoid dendritic cells (PDC). PDC were exposed to HIV-1NL4-3 at 4 °C for 30 min and then incubated at 37 °C for different
time periods. Cells were labeled using a biotinylated antibody to the viral p24 capsid antigen (red), and monoclonal antibodies (green) to (A) the Rab GTPases 5, 7, and 9, (B) the
tetraspanins CD63 and CD81, and the marker protein for recycling endosomes, CD71. Cell nuclei were stained using DAPI (blue). For quantiﬁcation, double-positive cells were
counted and the proportion of cells with a colocalization event was calculated. Data represent three independent confocal experiments, evaluating a total of 366, 412, and 304
double-positive cells for Rab5/7/9, and 368, 197 and 192 double-positive cells for CD63, CD81 or CD71. Data summarize all time points and are given as mean and standard
error. Details are provided in Fig. S2. ***pb0.001.
159K. Pritschet et al. / Virology 423 (2012) 152–164dependent scission of clathrin- and caveolin-coated pits from the plas-
mamembrane (Macia et al., 2006). A role of dynamin was also recently
reported for the entry of HIV-1 into macrophages (Carter et al., 2011).
Similarly, our data argue in favor of a dynamin-dependent uptake of
HIV-1 into PDC to induce IFN-alpha production. As dynasore did not
abolish IFN-alpha production completely, dynamin-independent path-
ways should also be considered. For instance, the role of autophagy-
dependent viral recognition by PDC has been recently described (Lee
et al., 2007). However, the signal for the autophagy marker LC3B was
rather marginal, when we analyzed PDC with a respective antibody in
confocal microscopy (data not shown).
Our confocal studies revealed that virions were internalized in
caveolin-1 positive compartments (Fig. 7A). This was unexpectedas caveolin-containing vesicles are reported to be much smaller
(50–80 nm in diameter) than the relatively large HIV-loaded vesicles
in the electron microscopy. However, endocytic vesicles appear to
accommodate to their cargo, and several vesicles can merge into multi-
vesicular bodies. Although clathrin-mediated endocytosis plays an im-
portant role for the entry of HIV-1 into several cell types (Permanyer
et al., 2010), only a minority of particles colocalized with clathrin in
our studies. However, these data are consistent, as clathrin colocalized
with the transferrin receptor CD71, whereas neither of these markers
costained with p24 antigen. Therefore, clathrin-mediated endocytosis
of HIV-1 into PDC appears to be unlikely. Beyond that, other ways of en-
docytosis should be considered, which may also involve uptake of
caveolin as part of the lipid rafts. In this respect, a recent study provided
Fig. 7. Characterization of entrymechanism of HIV-1 into PDC. (A) PDCwere exposed to HIV-1NL4-3 at 4 °C for 30 min and then incubated at 37 °C for different time periods. Cells were stained
using a biotinylated antibody to the viral p24 capsid antigen (red) andmonoclonal antibodies against clathrin or caveolin-1 (green). For quantiﬁcation, double-positive cells were counted and
the proportion of cells with a colocalization event was calculated. Cell nuclei were stained using DAPI (blue). Data represent three independent confocal experiments, evaluating a total of 111
and 152double-positive cells for clathrin and caveolin-1, respectively. The results summarize all timepoints and are given asmean and standard error. *pb0.05. As a control, HIV-1 exposed PDC
of two different donors were stained with antibodies against clathrin (green) and CD71 (red). Results are representative for 172, 282, and 180 double-positive cells at 5, 15, and 30min of in-
cubation, respectively. (B) PDCwerepreincubatedwithmock (media), anti-CD4, human IgG (isotype for anti-CD4), anti-BDCA2, or goat IgG (isotype for BDCA2) for 2 h at 37 °C before theywere
exposed to HIV-1NL4-3 at 37 °C for 45 min. Cells were labeled with DAPI (blue), anti-p24 (red) and anti-EEA1 (green) and subsequently analyzed by confocal microscopy. The upper and lower
panels show endosomal and cytosolic viral particles, respectively. The results are representative of two independent experiments.
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to mediate IFN-alpha induction in PDC (Boasso et al., 2011).
The role of the CD4 receptor in the uptake of HIV-1 into PDC has
been studied using antibodies against CD4, soluble CD4, and neutraliz-
ing antibodies to gp120, which blocked the HIV-1 induced IFN-alpha
production (Beignon et al., 2005; Herbeuval et al., 2005a; Schmidt
et al., 2005; Yonezawa et al., 2003). Correspondingly, changes in the
gp120 protein that impaired CD4 binding and infectivity reduced the
capacity of these viruses to induce IFN-alpha production (Haupt et al.,
2008). An antibody to CD4 reduced the uptake of HIV-1 into PDC
(Fig. 3E), although this effect was not as pronounced as in CD4+ T
cells, suggesting that other factors are involved. More convincing were
the blocking experiments, in which anti-CD4 inhibited the uptake of
HIV-1 into cytosolic and endosomal compartments (Fig. 7B). These
data conﬁrm the crucial role of CD4 in the attachment and uptake of
HIV-1 into PDC.
It remains unclear whether HIV-1 particles, viral capsids and/or
nucleic acids can evade from the endosome into the cytosol and estab-
lish a productive infection, as reported for inﬂuenza viruses and others.
HIV-1 was reported to establish productive infection in CD4+ HeLa
cells after endocytosis (Daecke et al., 2005). Supporting evidence
comes from studies reporting augmented HIV-1 infection after blocking
lysosomal degradation (Fredericksen et al., 2002; Schaeffer et al., 2004;
Wei et al., 2005). Myeloid dendritic cells can engulf viral particles and
pass them on in an infectious form to CD4+ T cells (Cameron et al.,
1992; Pope et al., 1994). This infection in trans is mediated by the C-
type lectin DC-SIGN (Geijtenbeek et al., 2000). PDC can also transmit in-
fectious viral particles to CD4+ T cells (Fong et al., 2002; Schmidt et al.,
2004). However, the lack of colocalizationwith CD71 argues against this
recycling mechanism in PDC (Fig. 6B).
The HIV-1 induced IFN-alpha production can be inhibited by
blocking endosomal acidiﬁcation (Beignon et al., 2005; Hardy et al.,
2007; Schmidt et al., 2005; Lepelley et al., 2011). Hence, those parti-
cles which end up in the endosomes appear to be important for the
IFN-alpha induction, supported by the colocalization of HIV-1 virions
with late endosomal markers like Rab GTPases 7 and 9 and LAMP-1
(Figs. 5, 6). Subsequent release of viral nucleic acids may promote
the interaction with the endosomal Toll-like receptors, as proposed
by others (Beignon et al., 2005; Heil et al., 2004; Mandl et al., 2008;
Lepelley et al., 2011). This concept may be physiologically relevant,
because a very recent clinical study showed that the immune activa-
tion in 20 HIV-1 infected patients could be reduced by the administra-
tion of hydroxychloroquine (Piconi et al., 2011). Thus, our study
provides new insights into the mechanisms by which PDC may con-
tribute to the HIV-1 immunopathogenesis. These ﬁndings may en-
courage new therapeutic concepts that reduce the chronic immune
activation in HIV-1 infection by inhibitors which interfere with the
endocytic pathway.
Materials and methods
Isolation and cultivation of cells
PBMC were isolated from EDTA-anticoagulated blood of healthy
volunteers using Ficoll density gradient centrifugation (Biochrom
AG, Berlin, Germany), approved by the ethical committee of the
Medical Faculty, Friedrich-Alexander Erlangen-Nürnberg (Ref. no.
3375). CD4+ T cells were puriﬁed from PBMC using a magnetic
bead isolation kit (Miltenyi Biotech, Bergisch-Gladbach, Germany),
and cultivated at a density of 3×106cells/ml in RPMI 1640 (Gibco,
Eggenstein, Germany) with 10% heat-inactivated (56 °C, 60 min)
fetal calf serum (FCS) (Lonza, Basel, Switzerland), 50 mg/ml gluta-
mine, 200 U/ml penicillin, and 90 U/ml streptomycin. Prior to HIV-
1 infection, CD4+ T cells were stimulated with 1 μg/ml phytohemag-
glutinin (PHA) (Oxoid GmbH, Wesel, Germany) and 20 U/ml IL-2
(Roche Pharma, Reinach, Switzerland) for 3 days. PDC were isolatedfrom PBMC using the BDCA4+ cell isolation kit (Miltenyi Biotech) (28).
Cell viability was determined by trypan blue staining. The purity of iso-
lated PDC, determined by CD4 and BDCA2 staining, was above 95%. PDC
were plated at a density of 0.5–1×106cells/ml in 24-well ﬂat bottom
plates unless indicated otherwise, and cultivated in the presence of
20 ng/ml IL-3 (R & D Systems, Wiesbaden-Nordenstadt, Germany).
293 T cells were cultivated in DMEM (Gibco) plus supplements.
Biologic reagents
The chimeric CD4 antibody (Leu3a) containing a murine Fab and a
human Fc was kindly provided by Becton Dickinson, the p24 (71-31)
antibody and the Trimeris/Roche fusion inhibitor T-20 (9845) by the
NIH AIDS Research and Reference Reagent Program, Germantown,
Maryland, and the TLR 7 agonist S-27609 by 3M Pharmaceuticals (St.
Paul, MN). The cell-culture grade BDCA2 and isotype control antibody
were obtained fromR&D Systems (Wiesbaden-Nordenstadt, Germany),
DMSO from AppliChem (Darmstadt, Germany), and dynasore (dis-
solved in DMSO) from Sigma-Aldrich (Taufkirchen, Germany).
Generation of virus stocks
PHA-stimulated CD4+ T cells were infected with the X4-tropic pri-
mary isolate HIV-1SF33 (Tateno and Levy, 1988). At peak viral replica-
tion, ﬂuids were transferred to PHA-stimulated PBMC. Supernatants
harvested at 3 days of infection were ﬁltered through a 0.22 μM
Millex-GS unit (Millipore, Schwalbach, Germany) and stored in ali-
quots. The tissue culture infectious dose 50% (TCID50) was determined
in PHA and IL-2 stimulated PBMC (McDougal et al., 1985). PDC were
generally exposed to HIV-1SF33 at a multiplicity of infection (MOI) of
1. For HIV-1NL4-3 stocks, 293 T cells were plated in tissue culture dishes
(Greiner Bio-one GmbH, Frickenhausen, Germany) and transfected at
80–90% conﬂuency using FuGENE HD (Roche, Mannheim, Germany)
(Haupt et al., 2008). Supernatants were ultracentrifuged through a
20% sucrose cushion (Beckmann SW41 rotor; 27,000 rpm, 90 min,
4 °C). An equivalent of 0.1–1 μg p24 antigen was used to infect 1×104
cells.
Quantiﬁcation of virus
The abundance of HIV-1 RNA in the cellular fractionation experi-
ments was quantiﬁed by the HIV-1 RealTime assay (Abbott,
Wiesbaden-Delkenheim, Germany), and the amounts of p24 antigen
by the Murex HIV antigen monoclonal antibody kit (Abbott).
Immuno-electron microscopy
Cells were exposed to HIV-1SF33 (MOI 1) or concentrated HIV-1NL4-3
at 37 °C for 60-90 min, ﬁxed in 4% paraformaldehyde and 0.5% glutaral-
dehyde at room temperature (RT) for 90 min, incubated in 50 mM
NH4Cl for 10 min, and permeabilised in 0.2% Triton X-100 for 5 min.
For pre-embedding immunostaining, a p24 antibody (71-31; 1:6) and
a 12 nm Gold-conjugated anti-human IgG (Dianova, Hamburg, Germa-
ny; 1:20) were used. Cells were poststained with 1% osmium tetroxide
for 60 min, dehydrated with ethanol/0.2% (wt/vol) uranyl acetate, and
embedded in epon with propylenoxide. Polymerisation was performed
at 60 °C for 3 days prior to sectioning with an Ultracut S microtome
(Reichert-Jung). Sectionswere transferred to slot grids coatedwith Pio-
loform (Plano, Wetzlar, Germany), analyzed at a Technai™ G2 electron
microscope (FEI Company, Eindhoven, The Netherlands) at 120 kV, and
recordedwith a 2 KMegaView III digital camera (Olympus Software Im-
aging Solutions) at calibrated magniﬁcations. For post-embedding
immunostaining, cells ﬁxed with 4% paraformaldehyde and 0.05% glu-
taraldehydewere dehydrated by graded alcohol, applying 0.5% uranyla-
cetate with 30% ethanol to enhance section contrast, and embedded in
Lowicryl (HM20) according to the progressive lowering temperature
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were incubated on droplets of blocking buffer (5% milk powder in
DPBS) for 30 min, the p24 antibody (diluted 1:10 in DPBS with 0.5%
BSA and 0.1% gelatine), and a 10 nm Gold-conjugated goat anti-
human antibody (BBI, diluted 1:20 in PBSwith 0.5% BSA and 0.1% gel-
atine) for 1 h. After ﬁxation with 1% glutaraldehyde in 0.05% HEPES
buffer, samples were counterstained with 2% uranyl acetate and
lead citrate. Sections were examined using a TEM 902 (Carl Zeiss
SMT AG, Germany) at 80 kV, and images were digitized using a
slow-scan charge-coupled-device camera (Pro Scan; Scheuring,
Germany).
Cellular fractionation
Cellular fractionation was performed as described by others (Janas et
al., 2008;Marechal et al., 1998). A total of 1×106 cellswere used for each
condition. Since this quantity of PDC was not readily isolated from one
donor, cells from 3 to 4 donors were pooled immediately prior to HIV-
1 exposure. Cells were preincubated with anti-CD4 (15 μg/ml) for 2 h
or the fusion inhibitor T-20 (100 nM, 300 nM, 500 nM and 1 μM) for
30 min before HIV-1SF33 was added. Cells were either incubated at
37 °C or kept on ice, then washed with ice-cold DPBS plus 0.1% FCS. All
sedimentation steps were carried out at 4 °C in a pre-chilled centrifuge.
To remove surface-bound HIV-1 particles, cells were treated with
0.25 mg/ml Pronase E (Sigma-Aldrich) in 20 mM HEPES buffer at 4 °C
for 10 min, terminated by adding medium plus 10% FCS. Cells were
washed twice using ice-cold DPBS plus 0.1% FCS and resuspended in
2 ml of swelling buffer (10 mM Tris–HCl, pH 8.0; 10 mM KCl; 1 mM
EDTA). After incubation on ice for 15 min, cells were disrupted by 15
strokes of dounce homogenization. Debris and nuclear fractionswere re-
moved by centrifugation at 3000 rpm for 3 min. Supernatantswere sedi-
mented at 50,000 rpm for 13 min using a Beckman SW60Ti rotor to
separate vesicles and cytosol. These conditions were validated using Jur-
kat T cells; supernatants of these cells were ultracentrifuged at 0–5–7–
10–13–18–23–28 min and then analyzed using LAMP-1 Western blot-
ting (data not shown). For further analysis, we adjusted the cytosolic
fraction to 0.5% TritonX-100. Thevesicular extractwas lysed in a solution
containing 20 mM HEPES, 0.5% Triton X-100, and 150 mM NaCl.
Western blot
Cytosolic and vesicular extracts of HIV-1 exposed PDC were prepared
as described above. The vesicular pellet was resuspended in lysis buffer
(50 mM TRIS, pH 8.0; 150 mM NaCl; 5 mM EDTA; 1% NP-40; 0.1 mM
PMSF). The volume of the cytosolic fractionwas adjusted to the vesicular
fraction using Amicon Ultra-4 Centrifugal Filter Units with Ultracel-30
membrane (Millipore). The SDS-denatured samples were separated on
a 10% polyacrylamide gel, transferred to a PVDF membrane (Millipore),
and blockedwith 5%milk powder. The LAMP-1 antibody (Natutec, Frank-
furt, Germany; 1:500) was incubated at 4 °C overnight and a HRP-
conjugated rabbit polyclonal anti-mouse IgG (H+L) (DAKO Diagnostics
GmbH, Hamburg; 1:1000) at RT for 90 min. After addition of ECL solution
containing luminol (Sigma) for 1 min, luminescence was documented
using the Fujiﬁlm LAS-1000 plus gel documentation system.
IFN-alpha assays
PDC were plated at 1×104 cells in 96-well plates, pretreated with
T-20 (100 and 300 nM), and stimulated with UV-inactivated herpes
simplex virus type 1 (HSV-1) at 1×106PFU/ml (Schuster et al.,
2010) or HIV-1NL4-3. In other experiments, PDC were preincubated
with dynasore (80 μM) or equivalent volumes of DMSO, and exposed
to S-27609 (5 μM) or HIV-1NL4-3. In some experiments, PDC were in-
cubated with dynasore and HIV-1 in serum-free media; after 2 h, FCS
was added. Supernatants were harvested after 36 h and IFN-alphaproduction was analyzed using an ELISA module set (Bender MedSys-
tems, Vienna, Austria).Confocal microscopy
PDC were cultivated in IL-3 containing medium overnight before
they were incubated with HIV-1SF33 or HIV-1NL4-3 at 4 °C for
30–60 min and then at 37 °C for different time periods. Cells were
washed once in cold DPBS, transferred to glass slides (Medco Diag-
nostika GmbH, Munich, Germany), and ﬁxed with 4% PFA for 1 h.
Slides were washed three times in DPBS plus 0.05% Tween 20,
blocked and permeabilised in DPBS with 1% BSA and 0.02% saponin
for 30 min. The biotinylated goat anti-p24 antibody (1:100) (Viro-
Stat, Portland, ME) was incubated at 4 °C overnight together with
the respective primary antibodies, the murine antibodies against
LAMP-1 (see above; 1:100), CD71 (Acris Antibodies, Herford, Ger-
many; 1:100), CD63 (1:1000) and CD81 (1:1000) (BD Biosciences,
Heidelberg, Germany), or rabbit antibodies against EEA-1 (1:100),
the Rab GTPases 5 (1:100), 7 (1:50), and 9 (1:100), Clathrin (1:50),
and Caveolin-1 (1:400) (Cell Signaling, distributed by New England
Biolabs, Frankfurt, Germany). Mouse IgG1 (Immunotools, Frie-
soythe, Germany) and rabbit IgG (Cell Signaling) served as isotype
controls. After three washing steps, slides were incubated with an
Alexa Fluor 488-conjugated goat F(ab′)2 fragment anti-mouse IgG
(H+L) antibody (1:1000) or an Alexa Fluor 488-conjugated goat F
(ab′)2 fragment anti-rabbit IgG (H+L) (1:500) (both Invitrogen,
Karlsruhe, Germany), and Streptavidin-TRITC (1:75) (Serotec, Düs-
seldorf, Germany) at RT for 90 min. DAPI (300 nM) was added
5 min prior to mounting the coverslips using Fluoprep (Biomérieux,
Nürtingen, Germany) or Vectashield (Biozol, Eiching, Germany).
Cells were analyzed using the TCS SP5 laser scanning microscope
equipped with the LAS-AF software (LeicaMicrosystems, Mannheim,
Germany). To quantify the colocalization of the viral capsid protein
p24 with cellular markers, double-labeled cells were counted and
the proportion of cells with a colocalization event was calculated.
Movies were obtained using the Leica Visualization 3D-Projection
program. For the blocking experiments, PDC were preincubated
with the antibodies to CD4 or BDCA2 (7.5–15 μg/ml) or the respec-
tive isotype controls for 2 h at 37 °C prior to HIV-1 exposure. Confo-
cal staining was performed as described above.Statistics
The abundance of HIV-1 RNA in different cell fractions, IFN-alpha
values, and colocalization events were compared using the Student's
t-tests for paired and unpaired samples. Two-sided p valuesb0.05
were considered signiﬁcant.
Supplementary data to this article can be found online at doi:10.
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